C-Terminal-PEDF Reduces IC50 Doses and Chemoresistant Population of CD133 and BCRP1-Positve Cancer Stem Like Cells. J. Anal. Oncol. [Internet]. 2013 Dec. 28 [cited 2026 Jul. 7];2(4):195-208. Available from: https://www.neoplasiaresearch.com/index.php/jao/article/view/87